176 related articles for article (PubMed ID: 1968737)
1. [Proto-oncogene C-erbB-2 and human cancer].
Toyoshima K
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):309-14. PubMed ID: 1968737
[TBL] [Abstract][Full Text] [Related]
2. Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract.
Zhang X; Silva E; Gershenson D; Hung MC
Oncogene; 1989 Aug; 4(8):985-9. PubMed ID: 2569708
[TBL] [Abstract][Full Text] [Related]
3. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.
Semba K; Kamata N; Toyoshima K; Yamamoto T
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6497-501. PubMed ID: 2995967
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.
Singleton TP; Strickler JG
Pathol Annu; 1992; 27 Pt 1():165-90. PubMed ID: 1346551
[TBL] [Abstract][Full Text] [Related]
5. [Amplification and expression of oncogenes in human malignant tumors--organ or tissue specificity and prognosis].
Ueda M; Shimizu N; Abe O
Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1579-81. PubMed ID: 2573817
[TBL] [Abstract][Full Text] [Related]
6. Co-amplification of c-myc and c-erbB-2 oncogenes in a poorly differentiated human gastric cancer.
Tsuchiya T; Ueyama Y; Tamaoki N; Yamaguchi S; Shibuya M
Jpn J Cancer Res; 1989 Oct; 80(10):920-3. PubMed ID: 2575609
[TBL] [Abstract][Full Text] [Related]
7. Amplification of the c-erbB-2 gene in gastric carcinoma: correlation with survival.
Tsugawa K; Fushida S; Yonemura Y
Oncology; 1993; 50(6):418-25. PubMed ID: 7901825
[TBL] [Abstract][Full Text] [Related]
8. Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer.
Lemoine NR; Staddon S; Dickson C; Barnes DM; Gullick WJ
Oncogene; 1990 Feb; 5(2):237-9. PubMed ID: 2181382
[TBL] [Abstract][Full Text] [Related]
9. Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.
Yokota J; Yamamoto T; Toyoshima K; Terada M; Sugimura T; Battifora H; Cline MJ
Lancet; 1986 Apr; 1(8484):765-7. PubMed ID: 2870269
[TBL] [Abstract][Full Text] [Related]
10. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
[TBL] [Abstract][Full Text] [Related]
11. Amplification of c-myc and c-erbB-2 proto-oncogenes in human solid tumors: frequency and clinical significance.
Gutman M; Ravia Y; Assaf D; Yamamoto T; Rozin R; Shiloh Y
Int J Cancer; 1989 Nov; 44(5):802-5. PubMed ID: 2573579
[TBL] [Abstract][Full Text] [Related]
12. Amplification of ERBB-2 (HER-2/NEU) oncogene in different neoplasms of patients from USSR.
Knyazev PG; Imyanitov EN; Chernitca OI; Nikiforova IF; Hanson KP
Oncology; 1992; 49(2):162-5. PubMed ID: 1349430
[TBL] [Abstract][Full Text] [Related]
13. Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma.
Weidner U; Peter S; Strohmeyer T; Hussnätter R; Ackermann R; Sies H
Cancer Res; 1990 Aug; 50(15):4504-9. PubMed ID: 1973362
[TBL] [Abstract][Full Text] [Related]
14. [The erbB-related protooncogenes encoding growth factor receptors].
Yamamoto T; Toyoshima K
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2075-82. PubMed ID: 3496852
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors.
Nagai MA; Marques LA; Torloni H; Brentani MM
Oncology; 1993; 50(6):412-7. PubMed ID: 7901824
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.
Shiga K; Shiga C; Sasano H; Miyazaki S; Yamamoto T; Yamamoto M; Hayashi N; Nishihira T; Mori S
Anticancer Res; 1993; 13(5A):1293-301. PubMed ID: 7902061
[TBL] [Abstract][Full Text] [Related]
17. The erbB gene and the EGF receptor.
Martin GS
Cancer Surv; 1986; 5(2):199-219. PubMed ID: 2877733
[TBL] [Abstract][Full Text] [Related]
18. Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes.
Burgart LJ; Robinson RA; Haddad SF; Moore SA
Mod Pathol; 1991 Mar; 4(2):183-6. PubMed ID: 1675468
[TBL] [Abstract][Full Text] [Related]
19. Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy.
Hynes NE
Semin Cancer Biol; 1993 Feb; 4(1):19-26. PubMed ID: 8095411
[TBL] [Abstract][Full Text] [Related]
20. Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancer.
Kerns BJ; Jordan PA; Huper G; Marks JR; Iglehart JD; Layfied LJ
Mod Pathol; 1993 Nov; 6(6):673-8. PubMed ID: 7905629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]